Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of the ABCA1 Inducer R3R01 on Albuminuria Levels in Diabetic Kidney Disease

NCT06600412 is registered in ClinicalTrials.gov with River 3 Renal Corp. as lead sponsor.

NCT NCT06600412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06600412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of the ABCA1 Inducer R3R01 on Albuminuria Levels in Diabetic Kidney Disease
Lead sponsor
River 3 Renal Corp.
Phase
Phase 2
Overall status
Recruiting
Start date
October 10, 2024
Completion date
April 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic kidney disease